Showing results (151-160 of 175) with videos related to
Sort By:
Pageof 18
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 7, 2025
Host-pathogen hybrid glycocalyx mimicking lipid nanoparticles induce trained immunity as a promising platform for universal vaccinesXueying Tang, Yuejia Sun, Jiashuo Zhang, et al.Molecular Pharmaceutics|February 26, 2024
Sialic Acid Conjugate-Modified Cationic Liposomal Paclitaxel for Targeted Therapy of Lung Metastasis in Breast Cancer: What a Difference the Cation Content MakesWenliang Sun, Chao Han, Ruirui Ge, et al.Drug Delivery and Translational Research|January 2, 2024
The selection of animal models influences the assessment of anti-tumor efficacy: promising sialic acid-conjugate modified liposomes demonstrate remarkable therapeutic effects in diverse mouse strainsLu Wei, Lin Lin, Jia Wang, et al.Biomaterials Science|February 26, 2020
Sialic acid-conjugate modified liposomes targeting neutrophils for improved tumour therapyCong Li, Qiujun Qiu, Min Liu, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 10, 2023
Simultaneous dendritic cells targeting and effective endosomal escape enhance sialic acid-modified mRNA vaccine efficacy and reduce side effectsXueying Tang, Jiashuo Zhang, Dezhi Sui, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 4, 2023
Potent gene delivery from fluorinated poly(β-amino ester) in adhesive and suspension difficult-to-transfect cells for apoptosis and ferroptosisYihui Deng, Jing Zhang, Ximeng Sun, et al.AAPS Pharmscitech|May 17, 2019
Dual-Ligand Modification of PEGylated Liposomes Used for Targeted Doxorubicin Delivery to Enhance Anticancer EfficacyCong Li, Chaoyang Lai, Qiujun Qiu, et al.Pharmaceutical Research|May 12, 2019
Neutrophil-Mediated Delivery of Dexamethasone Palmitate-Loaded Liposomes Decorated with a Sialic Acid Conjugate for Rheumatoid Arthritis TreatmentLing Hu, Xiang Luo, Songlei Zhou, et al.International Journal of Pharmaceutics|January 12, 2025
Sialic acid-modified nanomedicines modulate neutrophils for dual therapy of cancer and sepsis: addressing neglected sepsis comorbidities during cancer treatmentYantong Li, Shuo Wang, Xinying Guan, et al.International Journal of Pharmaceutics|December 10, 2022
Persistent immune response: Twice tumor exfoliation induced by sialic acid-modified vincristine sulfate liposomesXinyang Yan, Xin Gao, Xiaoya Li, et al.Pageof 18